ESMO Press Releases

If you require further information regarding any of the press releases listed below, please do not hesitate to contact us (select 'Press & Media').

Filter

Date Title Topic
05 Nov 2019 2019 ESMO Award for Immuno-Oncology goes to Thomas Gajewski Personalised medicine - Cancer Immunology and Immunotherapy
30 Sep 2019 Adding immunotherapy to chemotherapy prolongs progression free survival in bladder cancer [ESMO 2019 Press Release] Genitourinary cancers
30 Sep 2019 Targeted Therapy Slows Progression of Advanced Prostate Cancer [ESMO 2019 Press Release] Genitourinary cancers
30 Sep 2019 First Targeted Therapy for Cholangiocarcinoma Shows Clinical Benefit in Phase III Trial [ESMO 2019 Press Release] Gastrointestinal cancers
30 Sep 2019 Mesothelioma Trial Suggests Immunotherapy as an Alternative to Chemotherapy [ESMO 2019 Press Release] Lung and other thoracic tumours
30 Sep 2019 Blood Test Can Replace Invasive Biopsy for More Patients with Lung Cancer [ESMO 2019 Press Release] Lung and other thoracic tumours
29 Sep 2019 Two Studies Show CDK4/6 Inhibitors Improve Overall Survival in Advanced Breast Cancer [ESMO 2019 Press Release] Breast cancer
29 Sep 2019 Immune Therapy Eliminates Tumour Cells in Early Triple Negative Breast Cancer [ESMO 2019 Press Release] Breast cancer
28 Sep 2019 Front-Line Osimertinib Improves Overall Survival in EGFR-Mutation Positive NSCLC [ESMO 2019 Press Release] Lung and other thoracic tumours
28 Sep 2019 Two Immunotherapy Drug Combination Offers Chemotherapy-Free Option for Advanced NSCLC [ESMO 2019 Press Release] Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
28 Sep 2019 Ovarian Cancer: More Women Benefit from Maintenance Combined Targeted Therapy [ESMO 2019 Press Release] Gynaecologic malignancies
28 Sep 2019 Liquid Biopsy has Prognostic Role in Colorectal Cancer and Potential for Guiding Therapy [ESMO 2019 Press Release] Gastrointestinal cancers - Personalised medicine
28 Sep 2019 DNA Profiling May Hold Key to Better Treatment Options in Carcinoma of Unknown Primary [ESMO 2019 Press Release] Carcinoma of unknown primary site
28 Sep 2019 One in Two Patients with Metastatic Melanoma Alive after Five Years with Combination Immunotherapy [ESMO 2019 Press Release] Melanoma and other skin tumours - Cancer Immunology and Immunotherapy
27 Sep 2019 Men with Prostate Cancer can be Spared Radiotherapy after Surgery [ESMO 2019 Press Release] Genitourinary cancers